Hudock Inc’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35
| Closed | -$4K | – | 322 |
|
|
2022
Q3 | $4K | Hold |
35
| – | – | ﹤0.01% | 616 |
|
|
2022
Q2 | $4K | Hold |
35
| – | – | ﹤0.01% | 608 |
|
|
2022
Q1 | $5K | Hold |
35
| – | – | ﹤0.01% | 608 |
|
|
2021
Q4 | $5K | Hold |
35
| – | – | ﹤0.01% | 611 |
|
|
2021
Q3 | $5K | Hold |
35
| – | – | ﹤0.01% | 638 |
|
|
2021
Q2 | $6K | Hold |
35
| – | – | ﹤0.01% | 590 |
|
|
2021
Q1 | $5K | Hold |
35
| – | – | ﹤0.01% | 600 |
|
|
2020
Q4 | $5K | Hold |
35
| – | – | ﹤0.01% | 579 |
|
|
2020
Q3 | $5K | Hold |
35
| – | – | ﹤0.01% | 533 |
|
|
2020
Q2 | $5K | Hold |
35
| – | – | ﹤0.01% | 510 |
|
|
2020
Q1 | $4K | Hold |
35
| – | – | ﹤0.01% | 492 |
|
|
2019
Q4 | $5K | Sell |
35
-45
| -56% | -$6.18K | ﹤0.01% | 495 |
|
|
2019
Q3 | $9K | Hold |
80
| – | – | ﹤0.01% | 431 |
|
|
2019
Q2 | $11K | Hold |
80
| – | – | ﹤0.01% | 411 |
|
|
2019
Q1 | $12K | Hold |
80
| – | – | ﹤0.01% | 391 |
|
|
2018
Q4 | $9K | Hold |
80
| – | – | ﹤0.01% | 399 |
|
|
2018
Q3 | $12K | Hold |
80
| – | – | ﹤0.01% | 405 |
|
|
2018
Q2 | $11K | Hold |
80
| – | – | ﹤0.01% | 408 |
|
|
2018
Q1 | $10K | Buy |
80
+35
| +78% | +$4.78K | ﹤0.01% | 429 |
|
|
2017
Q4 | $5K | Hold |
45
| – | – | ﹤0.01% | 480 |
|
|
2017
Q3 | $5K | Hold |
45
| – | – | ﹤0.01% | 481 |
|
|
2017
Q2 | $5K | Hold |
45
| – | – | ﹤0.01% | 453 |
|
|
2017
Q1 | $4K | Hold |
45
| – | – | ﹤0.01% | 463 |
|
|
2016
Q4 | $4K | Hold |
45
| – | – | ﹤0.01% | 459 |
|
|
2016
Q3 | $4K | Hold |
45
| – | – | ﹤0.01% | 472 |
|
|
2016
Q2 | $4K | Hold |
45
| – | – | ﹤0.01% | 477 |
|
|
2016
Q1 | $3K | Sell |
45
-27,530
| -100% | -$2.43M | ﹤0.01% | 500 |
|
|
2015
Q4 | $3.12M | Buy |
27,575
+4,292
| +18% | +$462K | 1.39% | 16 |
|
|
2015
Q3 | $2.36M | Buy |
23,283
+13,068
| +128% | +$1.55M | 1.11% | 18 |
|
|
2015
Q2 | $1.27M | Buy |
10,215
+1,462
| +17% | +$176K | 0.58% | 23 |
|
|
2015
Q1 | $1.03M | Buy |
8,753
+6,999
| +399% | +$791K | 0.46% | 27 |
|
|
2014
Q4 | $179K | Sell |
1,754
-3,244
| -65% | -$317K | 0.08% | 103 |
|
|
2014
Q3 | $459K | Buy |
4,998
+4,614
| +1,202% | +$400K | 0.28% | 61 |
|
|
2014
Q2 | $32K | Buy |
384
+31
| +9% | +$2.37K | 0.04% | 270 |
|
|
2014
Q1 | $27K | Hold |
353
| – | – | 0.02% | 271 |
|
|
2013
Q4 | $24K | Hold |
353
| – | – | 0.02% | 292 |
|
|
2013
Q3 | $23K | Hold |
353
| – | – | 0.02% | 248 |
|
|
2013
Q2 | $21K | Buy |
+353
| New | +$20.2K | 0.03% | 256 |
|
Other funds holding FBT
RJFSA
RJA
BFG
Hudock Inc's FBT Position: Q4 2022 in Review
Hudock Inc sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2022, closing a stake of 35 shares — an estimated $4K sold.
Hudock Inc first reported a position in FBT in Q2 2013 and held it in 38 quarters. The position peaked at $3.12M in Q4 2015. 243 funds tracked by Wall St. Rank hold FBT as of Q4 2022.
- Hudock Inc reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2022 after selling out during the quarter.
- Hudock Inc sold 35 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2022, an estimated $4K.
- Hudock Inc first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 38 quarters.
- Hudock Inc's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.12M in Q4 2015.
- 243 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2022.
Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.